Project Details
Description
Long-term safety and efficacy of semaglutide s.c. once-weekly on weight management in children and adolescents (aged 6 to <18 years) with obesity or overweight
| Status | Active |
|---|---|
| Effective start/end date | 2/20/23 → 2/28/28 |
Funding
- NOVO NORDISK, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.